Pharma and Life Science
Unlock longitudinal real-world imaging data (RWiD) at scale.
Medical innovation goes beyond obtaining real-world data. It’s also about the full patient journey.
At Segmed, we want to connect disparate data silos – and we want to do this safely, reliably and compliantly.
We offer tokenized data, bringing you the most comprehensive longitudinal patient records available all while maintaining patient confidentiality.
At Segmed, we want to connect disparate data silos – and we want to do this safely, reliably and compliantly.
We offer tokenized data, bringing you the most comprehensive longitudinal patient records available all while maintaining patient confidentiality.
Learn more
Medical innovation goes beyond obtaining real-world data. It’s also about the full patient journey.
At Segmed, we want to connect disparate data silos – and we want to do this safely, reliably and compliantly.
We offer tokenized data, bringing you the most comprehensive longitudinal patient records available all while maintaining patient confidentiality.
At Segmed, we want to connect disparate data silos – and we want to do this safely, reliably and compliantly.
We offer tokenized data, bringing you the most comprehensive longitudinal patient records available all while maintaining patient confidentiality.
Learn more
Current Challenge:
Accessing longitudinal real-world data in oncology for complex case correlation, building a data lake to speed up treatments insights, innovations and R&D.
Use Cases:
Enhance comprehension of the correlation between features derived from initial CT (Computed Tomography) scans and the response as well as outcomes in NSCLC (Non-Small Cell Lung Cancer), Pancreatic Cancer., etc. to optimize protocols and refine guidelines further
Effectively establish an external control arm with longitudinal patient data
Benefits of Segmed Solution:
Rapidly access de-identified patient datasets with high quality, curation speed and diversity sourced from over 1,000 sites on 5 continents
Store and process fully de-identified patient data, compliant with HIPAA
Data Overview
Patient demographics (age, gender, race, and ethnicity where available)
Chemo regimen & how many cycles
Radiation (yes/ no) & how many cycles
Response Evaluation Criteria in Solid Tumors (RECIST) outcomes, time to progression & time to death (if applicable)
Resection (yes/ no/ when)
Volumetric analysis
Accelerate your development pipeline
Curate your training & validation datasets on Segmed Insight today!
© Segmed
#810-3790 El Camino Real, Palo Alto, CA, USA- 94306
#810-3790 El Camino Real, Palo Alto, CA, USA- 94306
